Dr. Xian is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
401 North Broadway
Weinberg 2237
Baltimore, MD 21231Phone+1 215-662-4829Fax+1 410-500-4266
Education & Training
UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Molecular Genetic Pathology, 2014 - 2015
Johns Hopkins UniversityFellowship, Hematopathology, 2013 - 2014
University of Pennsylvania Health SystemResidency, Pathology-Anatomic and Clinical, 2009 - 2013
Northwestern University The Feinberg School of MedicineClass of 2009
Certifications & Licensure
MD State Medical License 2018 - 2025
CA State Medical License 2014 - 2019
PA State Medical License 2009 - 2014- American Board of Pathology Pathology - Anatomic/Pathology - Clinical
- American Board of Pathology Pathology - Hematology
- American Board of Pathology Pathology - Molecular Genetic
Publications & Presentations
PubMed
- 31 citationsThe Liquid Biopsy Consortium: Challenges and opportunities for early cancer detection and monitoring.Syeda Maheen Batool, Anudeep Yekula, Prerna Khanna, Tiffaney Hsia, Austin S Gamblin
Cell Reports. Medicine. 2023-10-17 - 14 citationsIDH1 and IDH2 Mutations in Colorectal Cancers.Jialing Huang, Li Hui Tseng, Vamsi Parini, Parvez M. Lokhandwala, Aparna Pallavajjala
American Journal of Clinical Pathology. 2021-10-13 - 29 citationsCREBBP and STAT6 co-mutation and 16p13 and 1p36 loss define the t(14;18)-negative diffuse variant of follicular lymphomaRena R. Xian, Yi Xie, Lisa Haley, Raluca Yonescu, Aparna Pallavajjala
Blood Cancer Journal. 2020-06-17
Journal Articles
- Clinical Validation of Coexisting Driver Mutations in Colorectal CancersJunaid Ibrahim, James R Eshleman, Gang Zheng, Christopher D Gocke, Rena Xian, ScienceDirect
Authored Content
- Proficiency Testing of Standardized Samples Shows High Interlaboratory Agreement for Clinical Next Generation Sequencing–Based Hematologic Malignancy Assays with Survey Material–Specific Differences in Variant FrequenciesJanuary 2020
- Proficiency Testing of Standardized Samples Shows High Interlaboratory Agreement for Clinical Next Generation Sequencing–Based Hematologic Malignancy Assays with Survey Material–Specific Differences in Variant FrequenciesJanuary 2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
